ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

National Action Plan Issues RFA For Grant Supplements

April 21, 1995

Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan.

November 16, 2007

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995

Longer List of DCPC Spending Plans $40 Mll Increase

December 10, 1993

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011